Study | Location | Study date | Method | Estimated R0 | Other findings |
---|---|---|---|---|---|
Grabowski et al. | South Africa | October, 2020 to December, 2020 | Based on GISAID data available and Genome Sequence Analysis | Rt: 1.55 (95% CI 1.43–1.69) The relative advantage over other South Africa strains: 1.58 (95% CI 1.45–1.72) |